China Translational Regenerative Medicine Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Translational Regenerative Medicine market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Translational Regenerative Medicine market. Detailed analysis of key players, along with key growth strategies adopted by Translational Regenerative Medicine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Vericel

    • MEDIPOST

    • Takeda Pharmaceutical

    • Organogenesis Holdings

    • AxoGen

    • uniQure

    • Pharmicell

    • Avita Medical

    • Astellas Pharma

    • Osiris Therapeutics

    • Regenerys

    • Athersys

    • NuVasive

    By Type:

    • Stem Cell Therapy

    • Tissue Engineering

    • Gene Therapy

    By End-User:

    • Tissue Engineering Therapy

    • Wound Healing

    • Cartilage Repair

    • Other

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Translational Regenerative Medicine Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Translational Regenerative Medicine Market Size and Growth Rate of Stem Cell Therapy from 2016 to 2027

    • 1.3.2 China Translational Regenerative Medicine Market Size and Growth Rate of Tissue Engineering from 2016 to 2027

    • 1.3.3 China Translational Regenerative Medicine Market Size and Growth Rate of Gene Therapy from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Translational Regenerative Medicine Market Size and Growth Rate of Tissue Engineering Therapy from 2016 to 2027

    • 1.4.2 China Translational Regenerative Medicine Market Size and Growth Rate of Wound Healing from 2016 to 2027

    • 1.4.3 China Translational Regenerative Medicine Market Size and Growth Rate of Cartilage Repair from 2016 to 2027

    • 1.4.4 China Translational Regenerative Medicine Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Translational Regenerative Medicine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Translational Regenerative Medicine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Translational Regenerative Medicine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Translational Regenerative Medicine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Translational Regenerative Medicine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Translational Regenerative Medicine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Translational Regenerative Medicine Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Translational Regenerative Medicine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Translational Regenerative Medicine by Major Types

    • 3.4.1 Market Size and Growth Rate of Stem Cell Therapy

    • 3.4.2 Market Size and Growth Rate of Tissue Engineering

    • 3.4.3 Market Size and Growth Rate of Gene Therapy

    4 Segmentation of Translational Regenerative Medicine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Translational Regenerative Medicine by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Translational Regenerative Medicine in Tissue Engineering Therapy

    • 4.4.2 Market Size and Growth Rate of Translational Regenerative Medicine in Wound Healing

    • 4.4.3 Market Size and Growth Rate of Translational Regenerative Medicine in Cartilage Repair

    • 4.4.4 Market Size and Growth Rate of Translational Regenerative Medicine in Other

    5 Market Analysis by Regions

    • 5.1 China Translational Regenerative Medicine Production Analysis by Regions

    • 5.2 China Translational Regenerative Medicine Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Translational Regenerative Medicine Landscape Analysis

    • 6.1 North China Translational Regenerative Medicine Landscape Analysis by Major Types

    • 6.2 North China Translational Regenerative Medicine Landscape Analysis by Major End-Users

    7 Central China Translational Regenerative Medicine Landscape Analysis

    • 7.1 Central China Translational Regenerative Medicine Landscape Analysis by Major Types

    • 7.2 Central China Translational Regenerative Medicine Landscape Analysis by Major End-Users

    8 South China Translational Regenerative Medicine Landscape Analysis

    • 8.1 South China Translational Regenerative Medicine Landscape Analysis by Major Types

    • 8.2 South China Translational Regenerative Medicine Landscape Analysis by Major End-Users

    9 East China Translational Regenerative Medicine Landscape Analysis

    • 9.1 East China Translational Regenerative Medicine Landscape Analysis by Major Types

    • 9.2 East China Translational Regenerative Medicine Landscape Analysis by Major End-Users

    10 Northeast China Translational Regenerative Medicine Landscape Analysis

    • 10.1 Northeast China Translational Regenerative Medicine Landscape Analysis by Major Types

    • 10.2 Northeast China Translational Regenerative Medicine Landscape Analysis by Major End-Users

    11 Southwest China Translational Regenerative Medicine Landscape Analysis

    • 11.1 Southwest China Translational Regenerative Medicine Landscape Analysis by Major Types

    • 11.2 Southwest China Translational Regenerative Medicine Landscape Analysis by Major End-Users

    12 Northwest China Translational Regenerative Medicine Landscape Analysis

    • 12.1 Northwest China Translational Regenerative Medicine Landscape Analysis by Major Types

    • 12.2 Northwest China Translational Regenerative Medicine Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Vericel

      • 13.1.1 Vericel Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 MEDIPOST

      • 13.2.1 MEDIPOST Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Takeda Pharmaceutical

      • 13.3.1 Takeda Pharmaceutical Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Organogenesis Holdings

      • 13.4.1 Organogenesis Holdings Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 AxoGen

      • 13.5.1 AxoGen Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 uniQure

      • 13.6.1 uniQure Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Pharmicell

      • 13.7.1 Pharmicell Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Avita Medical

      • 13.8.1 Avita Medical Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Astellas Pharma

      • 13.9.1 Astellas Pharma Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Osiris Therapeutics

      • 13.10.1 Osiris Therapeutics Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 Regenerys

      • 13.11.1 Regenerys Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    • 13.12 Athersys

      • 13.12.1 Athersys Company Profile and Recent Development

      • 13.12.2 Market Performance

      • 13.12.3 Product and Service Introduction

    • 13.13 NuVasive

      • 13.13.1 NuVasive Company Profile and Recent Development

      • 13.13.2 Market Performance

      • 13.13.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Translational Regenerative Medicine Market Size and Growth Rate of Stem Cell Therapy from 2016 to 2027

    • Figure China Translational Regenerative Medicine Market Size and Growth Rate of Tissue Engineering from 2016 to 2027

    • Figure China Translational Regenerative Medicine Market Size and Growth Rate of Gene Therapy from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Translational Regenerative Medicine Market Size and Growth Rate of Tissue Engineering Therapy from 2016 to 2027

    • Figure China Translational Regenerative Medicine Market Size and Growth Rate of Wound Healing from 2016 to 2027

    • Figure China Translational Regenerative Medicine Market Size and Growth Rate of Cartilage Repair from 2016 to 2027

    • Figure China Translational Regenerative Medicine Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Translational Regenerative Medicine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Translational Regenerative Medicine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Translational Regenerative Medicine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Translational Regenerative Medicine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Translational Regenerative Medicine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Translational Regenerative Medicine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Translational Regenerative Medicine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Translational Regenerative Medicine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Translational Regenerative Medicine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Translational Regenerative Medicine by Different Types from 2016 to 2027

    • Table Consumption Share of Translational Regenerative Medicine by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Stem Cell Therapy

    • Figure Market Size and Growth Rate of Tissue Engineering

    • Figure Market Size and Growth Rate of Gene Therapy

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Translational Regenerative Medicine by Different End-Users from 2016 to 2027

    • Table Consumption Share of Translational Regenerative Medicine by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Tissue Engineering Therapy

    • Figure Market Size and Growth Rate of Wound Healing

    • Figure Market Size and Growth Rate of Cartilage Repair

    • Figure Market Size and Growth Rate of Other

    • Table China Translational Regenerative Medicine Production by Regions

    • Table China Translational Regenerative Medicine Production Share by Regions

    • Figure China Translational Regenerative Medicine Production Share by Regions in 2016

    • Figure China Translational Regenerative Medicine Production Share by Regions in 2021

    • Figure China Translational Regenerative Medicine Production Share by Regions in 2027

    • Table China Translational Regenerative Medicine Consumption by Regions

    • Table China Translational Regenerative Medicine Consumption Share by Regions

    • Figure China Translational Regenerative Medicine Consumption Share by Regions in 2016

    • Figure China Translational Regenerative Medicine Consumption Share by Regions in 2021

    • Figure China Translational Regenerative Medicine Consumption Share by Regions in 2027

    • Table North China Translational Regenerative Medicine Consumption by Types from 2016 to 2027

    • Table North China Translational Regenerative Medicine Consumption Share by Types from 2016 to 2027

    • Figure North China Translational Regenerative Medicine Consumption Share by Types in 2016

    • Figure North China Translational Regenerative Medicine Consumption Share by Types in 2021

    • Figure North China Translational Regenerative Medicine Consumption Share by Types in 2027

    • Table North China Translational Regenerative Medicine Consumption by End-Users from 2016 to 2027

    • Table North China Translational Regenerative Medicine Consumption Share by End-Users from 2016 to 2027

    • Figure North China Translational Regenerative Medicine Consumption Share by End-Users in 2016

    • Figure North China Translational Regenerative Medicine Consumption Share by End-Users in 2021

    • Figure North China Translational Regenerative Medicine Consumption Share by End-Users in 2027

    • Table Central China Translational Regenerative Medicine Consumption by Types from 2016 to 2027

    • Table Central China Translational Regenerative Medicine Consumption Share by Types from 2016 to 2027

    • Figure Central China Translational Regenerative Medicine Consumption Share by Types in 2016

    • Figure Central China Translational Regenerative Medicine Consumption Share by Types in 2021

    • Figure Central China Translational Regenerative Medicine Consumption Share by Types in 2027

    • Table Central China Translational Regenerative Medicine Consumption by End-Users from 2016 to 2027

    • Table Central China Translational Regenerative Medicine Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Translational Regenerative Medicine Consumption Share by End-Users in 2016

    • Figure Central China Translational Regenerative Medicine Consumption Share by End-Users in 2021

    • Figure Central China Translational Regenerative Medicine Consumption Share by End-Users in 2027

    • Table South China Translational Regenerative Medicine Consumption by Types from 2016 to 2027

    • Table South China Translational Regenerative Medicine Consumption Share by Types from 2016 to 2027

    • Figure South China Translational Regenerative Medicine Consumption Share by Types in 2016

    • Figure South China Translational Regenerative Medicine Consumption Share by Types in 2021

    • Figure South China Translational Regenerative Medicine Consumption Share by Types in 2027

    • Table South China Translational Regenerative Medicine Consumption by End-Users from 2016 to 2027

    • Table South China Translational Regenerative Medicine Consumption Share by End-Users from 2016 to 2027

    • Figure South China Translational Regenerative Medicine Consumption Share by End-Users in 2016

    • Figure South China Translational Regenerative Medicine Consumption Share by End-Users in 2021

    • Figure South China Translational Regenerative Medicine Consumption Share by End-Users in 2027

    • Table East China Translational Regenerative Medicine Consumption by Types from 2016 to 2027

    • Table East China Translational Regenerative Medicine Consumption Share by Types from 2016 to 2027

    • Figure East China Translational Regenerative Medicine Consumption Share by Types in 2016

    • Figure East China Translational Regenerative Medicine Consumption Share by Types in 2021

    • Figure East China Translational Regenerative Medicine Consumption Share by Types in 2027

    • Table East China Translational Regenerative Medicine Consumption by End-Users from 2016 to 2027

    • Table East China Translational Regenerative Medicine Consumption Share by End-Users from 2016 to 2027

    • Figure East China Translational Regenerative Medicine Consumption Share by End-Users in 2016

    • Figure East China Translational Regenerative Medicine Consumption Share by End-Users in 2021

    • Figure East China Translational Regenerative Medicine Consumption Share by End-Users in 2027

    • Table Northeast China Translational Regenerative Medicine Consumption by Types from 2016 to 2027

    • Table Northeast China Translational Regenerative Medicine Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Translational Regenerative Medicine Consumption Share by Types in 2016

    • Figure Northeast China Translational Regenerative Medicine Consumption Share by Types in 2021

    • Figure Northeast China Translational Regenerative Medicine Consumption Share by Types in 2027

    • Table Northeast China Translational Regenerative Medicine Consumption by End-Users from 2016 to 2027

    • Table Northeast China Translational Regenerative Medicine Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Translational Regenerative Medicine Consumption Share by End-Users in 2016

    • Figure Northeast China Translational Regenerative Medicine Consumption Share by End-Users in 2021

    • Figure Northeast China Translational Regenerative Medicine Consumption Share by End-Users in 2027

    • Table Southwest China Translational Regenerative Medicine Consumption by Types from 2016 to 2027

    • Table Southwest China Translational Regenerative Medicine Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Translational Regenerative Medicine Consumption Share by Types in 2016

    • Figure Southwest China Translational Regenerative Medicine Consumption Share by Types in 2021

    • Figure Southwest China Translational Regenerative Medicine Consumption Share by Types in 2027

    • Table Southwest China Translational Regenerative Medicine Consumption by End-Users from 2016 to 2027

    • Table Southwest China Translational Regenerative Medicine Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Translational Regenerative Medicine Consumption Share by End-Users in 2016

    • Figure Southwest China Translational Regenerative Medicine Consumption Share by End-Users in 2021

    • Figure Southwest China Translational Regenerative Medicine Consumption Share by End-Users in 2027

    • Table Northwest China Translational Regenerative Medicine Consumption by Types from 2016 to 2027

    • Table Northwest China Translational Regenerative Medicine Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Translational Regenerative Medicine Consumption Share by Types in 2016

    • Figure Northwest China Translational Regenerative Medicine Consumption Share by Types in 2021

    • Figure Northwest China Translational Regenerative Medicine Consumption Share by Types in 2027

    • Table Northwest China Translational Regenerative Medicine Consumption by End-Users from 2016 to 2027

    • Table Northwest China Translational Regenerative Medicine Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Translational Regenerative Medicine Consumption Share by End-Users in 2016

    • Figure Northwest China Translational Regenerative Medicine Consumption Share by End-Users in 2021

    • Figure Northwest China Translational Regenerative Medicine Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Vericel

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vericel

    • Figure Sales and Growth Rate Analysis of Vericel

    • Figure Revenue and Market Share Analysis of Vericel

    • Table Product and Service Introduction of Vericel

    • Table Company Profile and Development Status of MEDIPOST

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MEDIPOST

    • Figure Sales and Growth Rate Analysis of MEDIPOST

    • Figure Revenue and Market Share Analysis of MEDIPOST

    • Table Product and Service Introduction of MEDIPOST

    • Table Company Profile and Development Status of Takeda Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical

    • Table Product and Service Introduction of Takeda Pharmaceutical

    • Table Company Profile and Development Status of Organogenesis Holdings

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Organogenesis Holdings

    • Figure Sales and Growth Rate Analysis of Organogenesis Holdings

    • Figure Revenue and Market Share Analysis of Organogenesis Holdings

    • Table Product and Service Introduction of Organogenesis Holdings

    • Table Company Profile and Development Status of AxoGen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AxoGen

    • Figure Sales and Growth Rate Analysis of AxoGen

    • Figure Revenue and Market Share Analysis of AxoGen

    • Table Product and Service Introduction of AxoGen

    • Table Company Profile and Development Status of uniQure

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of uniQure

    • Figure Sales and Growth Rate Analysis of uniQure

    • Figure Revenue and Market Share Analysis of uniQure

    • Table Product and Service Introduction of uniQure

    • Table Company Profile and Development Status of Pharmicell

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pharmicell

    • Figure Sales and Growth Rate Analysis of Pharmicell

    • Figure Revenue and Market Share Analysis of Pharmicell

    • Table Product and Service Introduction of Pharmicell

    • Table Company Profile and Development Status of Avita Medical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Avita Medical

    • Figure Sales and Growth Rate Analysis of Avita Medical

    • Figure Revenue and Market Share Analysis of Avita Medical

    • Table Product and Service Introduction of Avita Medical

    • Table Company Profile and Development Status of Astellas Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma

    • Figure Sales and Growth Rate Analysis of Astellas Pharma

    • Figure Revenue and Market Share Analysis of Astellas Pharma

    • Table Product and Service Introduction of Astellas Pharma

    • Table Company Profile and Development Status of Osiris Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Osiris Therapeutics

    • Figure Sales and Growth Rate Analysis of Osiris Therapeutics

    • Figure Revenue and Market Share Analysis of Osiris Therapeutics

    • Table Product and Service Introduction of Osiris Therapeutics

    • Table Company Profile and Development Status of Regenerys

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Regenerys

    • Figure Sales and Growth Rate Analysis of Regenerys

    • Figure Revenue and Market Share Analysis of Regenerys

    • Table Product and Service Introduction of Regenerys

    • Table Company Profile and Development Status of Athersys

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Athersys

    • Figure Sales and Growth Rate Analysis of Athersys

    • Figure Revenue and Market Share Analysis of Athersys

    • Table Product and Service Introduction of Athersys

    • Table Company Profile and Development Status of NuVasive

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NuVasive

    • Figure Sales and Growth Rate Analysis of NuVasive

    • Figure Revenue and Market Share Analysis of NuVasive

    • Table Product and Service Introduction of NuVasive


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.